Skip to main content
logo
Takeda Pharmaceutical Company Limited (TYO:4502)
Japan flag Japan · Delayed Price · Currency is JPY
4,934.00
-103.00 (-2.04%)
Jun 19, 2026, 3:30 PM JST

TYO:4502 Revenue

In the fiscal year ending March 31, 2026, Takeda Pharmaceutical Company had annual revenue of 4.51T JPY, down -1.66%. Takeda Pharmaceutical Company had revenue of 1.09T in the quarter ending March 31, 2026, with 3.90% growth.

Revenue
4.51T
Revenue Growth
-1.66%
P/S Ratio
1.73
Revenue / Employee
94.95M
Employees
47,455
Market Cap
7.79T

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20264.51T-75.83B-1.66%
Mar 31, 20254.58T317.79B7.45%
Mar 31, 20244.26T236.28B5.87%
Mar 31, 20234.03T458.47B12.85%
Mar 31, 20223.57T371.20B11.61%
Mar 31, 20213.20T-93.38B-2.84%
Mar 31, 20203.29T1.19T56.93%
Mar 31, 20192.10T--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Toho Holdings1.55T
Eisai825.38B
Shionogi &499.68B
Sumitomo Pharma453.29B
Towa Pharmaceutical273.71B
Sawai Group Holdings201.68B
Tsumura & Co.192.62B
Nippon Shinyaku170.77B
Revenue Rankings

Takeda Pharmaceutical Company News

More News